GammaDelta Therapeutics has a total of 496 patents globally, out of which 62 have been granted. Of these 496 patents, more than 90% patents are active. Europe (EPO) is where GammaDelta Therapeutics has filed the maximum number of patents, followed by Hong Kong and Japan. Parallelly, United Kingdom seems to be the main focused R&D centre and also is the origin country of GammaDelta Therapeutics.
GammaDelta Therapeutics, founded in 2016 and based in the UK, develops allogeneic immunotherapies leveraging the unique properties of Vδ1+ γδ T cells to treat hematological cancers and solid tumors. Originating from research at King’s College London and the Francis Crick Institute, the company uses proprietary protocols to isolate and expand Vδ1+ T cells for clinical applications. Specialties include immunotherapy, γδ T cells, CAR T cells, and innate immune cell biology.
Do read about some of the most popular patents of GammaDelta Therapeutics which have been covered by us in this article and also you can find GammaDelta Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over GammaDelta Therapeutics patent portfolio.
How many patents does GammaDelta Therapeutics have?
GammaDelta Therapeutics has a total of 496 patents globally. These patents belong to 38 unique patent families. Out of 496 patents, 444 patents are active.
How Many Patents did GammaDelta Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | GammaDelta Therapeutics Applications Filed | GammaDelta Therapeutics Patents Granted |
| 2025 | 2 | 8 |
| 2024 | 40 | 28 |
| 2023 | 73 | 11 |
| 2022 | 93 | 8 |
| 2021 | 115 | 4 |
| 2020 | 64 | 1 |
| 2019 | 63 | 1 |
| 2018 | 24 | 1 |
| 2016 | 22 | – |
How many GammaDelta Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did GammaDelta Therapeutics File in Different Countries?
Countries in which GammaDelta Therapeutics Filed Patents
| Country | Patents |
| Europe (EPO) | 30 |
| Hong Kong (S.A.R.) | 30 |
| Japan | 26 |
| United States of America | 26 |
| Australia | 25 |
| China | 23 |
| Israel | 21 |
| Korea (South) | 21 |
| Canada | 20 |
| Brazil | 19 |
| Mexico | 19 |
| India | 18 |
| Indonesia | 17 |
| Singapore | 14 |
| United Kingdom | 14 |
| Malaysia | 13 |
| Eurasia | 13 |
| Colombia | 13 |
| Philippines | 12 |
| New Zealand | 11 |
| Viet Nam | 9 |
| Germany | 8 |
| Chile | 8 |
| Argentina | 8 |
| South Africa | 8 |
| Taiwan | 7 |
| Peru | 6 |
| Ecuador | 4 |
| Poland | 3 |
| Denmark | 3 |
| Norway | 3 |
| Italy | 3 |
| Portugal | 3 |
| Spain | 3 |
| Slovenia | 2 |
| Austria | 2 |
| Finland | 2 |
| Lithuania | 2 |
| Lebanon | 1 |
| Malta | 1 |
| Russia | 1 |
| Thailand | 1 |
Where are Research Centres of GammaDelta Therapeutics Patents Located?
10 Best GammaDelta Therapeutics Patents
WO2016198480A1 is the most popular patent in the GammaDelta Therapeutics portfolio. It has received 67 citations so far from companies like Hemosol & Syngenta.
Below is the list of 10 most cited patents of GammaDelta Therapeutics:
| Publication Number | Citation Count |
| WO2016198480A1 | 67 |
| WO2020095059A1 | 33 |
| WO2021032963A1 | 22 |
| WO2021032960A1 | 12 |
| WO2021032961A1 | 10 |
| WO2020095058A1 | 8 |
| CN110914410A | 4 |
| WO2022175413A1 | 3 |
| WO2022049550A1 | 3 |
| WO2022034562A1 | 3 |
What Percentage of GammaDelta Therapeutics US Patent Applications were Granted?
GammaDelta Therapeutics (Excluding its subsidiaries) has filed 23 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 50.00%.
Below are the key stats of GammaDelta Therapeutics patent prosecution at the USPTO.
Which Law Firms are managing US Patents for GammaDelta Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Sterne Kessler Goldstein & Fox Pllc | 17 | 50.00% |
| Wolf Greenfield & Sacks Pc | 3 | 0% |
| Takeda | 2 | 0% |
| Clark Elbing Llp | 1 | 0% |
What are GammaDelta Therapeutics key innovation segments?
What Technologies are Covered by GammaDelta Therapeutics?
The chart below distributes patents filed by GammaDelta Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where GammaDelta Therapeutics thinks it’s important to protect particular technological inventions.
R&D Focus: How has GammaDelta Therapeutics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by GammaDelta Therapeutics?
